Transmission of multidrug-resistant and extensively drug-resistant tuberculosis in a metropolitan city

European Respiratory Journal

Volumn 41, Issue 4, 2013, Pages 901-908

  Leung, Eric Chung Ching ^a   Leung, Chi Chiu ^a   Kam, Kai Man ^b   Yew, Wing Wai ^c   Chang, Kwok Chiu ^a   Leung, Wai Man ^a   Tam, Cheuk Ming ^a  

^a DEPARTMENT OF HEALTH   (Hong Kong)

^b DEPARTMENT OF HEALTH   (Hong Kong)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Case finding; Contact investigations; Extensively drug resistant tuberculosis; Multidrug resistant tuberculosis

Indexed keywords

ADULT; ARTICLE; BACTERIUM ISOLATE; COHORT ANALYSIS; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; ENVIRONMENTAL EXPOSURE; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; FEMALE; HOUSEHOLD; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MOLECULAR DIAGNOSIS; MOLECULAR FINGERPRINTING; MULTIDRUG RESISTANT TUBERCULOSIS; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RETROSPECTIVE STUDY; SCREENING; URBAN AREA;

ADULT; CITIES; CLUSTER ANALYSIS; COHORT STUDIES; CONTACT TRACING; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; FEMALE; HONG KONG; HUMANS; ISONIAZID; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREVALENCE; RETROSPECTIVE STUDIES; STREPTOMYCIN; TUBERCULOSIS, MULTIDRUG-RESISTANT; URBAN POPULATION;

EID: 84875844457     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00071212     Document Type: Article

References (32)

1. Mitnick CD, Shin SS, Seung KJ, et al. Comprehensive treatment of extensively drug-resistant tuberculosis. N Engl J Med 2008; 359: 563-574.
2. Keshavjee S, Gelmanova IY, Farmer PE, et al. Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study. Lancet 2008; 372: 1403-1409.
3. Grandjean L, Crossa A, Gilman RH, et al. Tuberculosis in household contacts of multidrug-resistant tuberculosis patients. Int J Tuberc Lung Dis 2011; 15: 1164-1169.
4. Becerra MC, Appleton SC, Franke MF, et al. Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: a retrospective cohort study. Lancet 2011; 377: 147-152.
5. Annual reports 1997 and 2009, Tuberculosis and Chest Service, Department of Health, Hong Kong. Available from: www.chp. gov.hk/en/data/4/10/26/43/91 and www.info.gov.hk/tb-chest/contents/c56.
6. World Health Organization. Anti-tuberculosis Drug Resistance in the World Report No. 4. The WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance. Geneva, WHO press, 2008.
7. Law WS, Yew WW, Chiu Leung C, et al. Risk factors for multidrug-resistant tuberculosis in Hong Kong. Int J Tuberc Lung Dis 2008; 12: 1065-1070.
8. Noertjojo K, Tam CM, Chan SL, et al. Contact examination for tuberculosis in Hong Kong is useful. Int J Tuberc Lung Dis 2002; 6: 19-24.
9. Leung CC, Tam CM, Chan SL, et al. Efficacy of the BCG revaccination programme in a cohort given BCG vaccination at birth in Hong Kong. Int J Tuberc Lung Dis 2001; 5: 717-723.
10. Leung ECC, Yew WW, Leung CC, et al. Shorter treatment duration for selected patients with multidrug-resistant tuberculosis. Eur Respir J 2011; 38: 227-230.
11. Hermans PW, van Soolingen D, Dale JW, et al. Insertion element IS986 fromMycobacterium tuberculosis: a useful tool for diagnosis and epidemiology of tuberculosis. J ClinMicrobiol 1990; 28: 2051-2058.
12. Laserson KF, Thorpe LE, Leimane V, et al. Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2005; 9: 640-645.
13. Murray M, Alland D. Methodological problems in the molecular epidemiology of tuberculosis. Am J Epidemiol 2000; 155: 565-571.
14. Murray M, Nardell E. Molecular epidemiology of tuberculosis: achievements and challenges to current knowledge. Bull World Health Organ 2002; 80: 477-482.
15. Gandhi NR, Moll A, Sturm AW, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006; 368: 1575-1580.
16. Zhao M, Li X, Xu P, et al. Transmission of MDR and XDR tuberculosis in Shanghai, China. PLoS One 2009; 4: e4370.
17. Leimane V, Dravniece G, Riekstina V, et al. Treatment outcome of multidrug/extensively drug-resistant tuberculosis in Latvia, 2000-2004. Eur Respir J 2010; 36: 584-593.
18. Murase Y, Maeda S, Yamada H, et al. Clonal expansion of multidrug-resistant and extensively drug-resistant tuberculosis, Japan. Emerg Infect Dis 2010; 16: 948-954.
19. Chan-Yeung M, Kam KM, Leung CC, et al. Population based prospective molecular and conventional epidemiological study of tuberculosis in Hong Kong. Respirology 2006; 11: 442-448.
20. Devaux I, Kremer K, Heersma H, et al. Clusters of multidrugresistant Mycobacterium tuberculosis cases, Europe. Emerg Infect Dis 2009; 15: 1052-1060.
21. Kam KM, Yip CW, Tse LW, et al. Trends in multidrug-resistant Mycobacterium tuberculosis in relation to sputum smear positivity in Hong Kong, 1989-1999. Clin Infect Dis 2002; 34: 324-329.
22. Lee MS, Leung CC, Kam KM, et al. Early and late tuberculosis risks among close contacts in Hong Kong. Int J Tuberculosis Lung Dis 2008; 12: 281-287.
23. Grandjean L, Crossa A, Gilman RH, et al. Tuberculosis in household contacts of multidrug-resistant tuberculosis patients. Int J Tuberc Lung Dis 2011; 15: 1164-1169.
24. Morrison J, Pai M, Hopewell PC. Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Infect Dis 2008; 8: 359-368.
25. Dahle UR. Extensively drug resistant tuberculosis: beware patients lost to follow-up. BMJ 2006; 333: 705.
26. Dahle UR, Sandven P, Heldal E, et al. Deciphering an outbreak of drug resistant Mycobacterium tuberculosis. J Clin Microbiol 2003; 41: 67-72.
27. Andersson DI. The biological cost of mutational antibiotic resistance: any practical conclusions? Curr Opin Microbiol 2006; 9: 461-465.
28. Metcalfe JZ, Kim EY, Lin SY, et al. Determinants of multidrugresistant tuberculosis clusters, California, USA, 2004-2007. Emerg Infect Dis 2010; 16: 1403-1409.
29. Lee JH, Ammerman NC, Nolan S, et al. Isoniazid resistance without a loss of fitness in Mycobacterium tuberculosis. Nat Commun 2012; 20: 753.
30. Comas I, Borrell S, Roetzer A, et al. Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes. Nat Genet 2011; 44: 106-110.
31. Dheda K, Migliori GB. The global rise of extensively drug-resistant tuberculosis: is the time to bring back sanatoria now overdue? Lancet 2012; 379: 773-775.
32. World Health Organization. Frequently asked questions-XDRTB. www.who.int/tb/challenges/xdr/faqs/en/index.html Date last accessed: 21/4/2012.